"10.1371_journal.pone.0034467","plos one","2012-04-04T00:00:00Z","William L Redmond; Todd Triplett; Kevin Floyd; Andrew D Weinberg","Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, United States of America; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon, United States of America","Conceived and designed the experiments: WLR TT ADW. Performed the experiments: WLR TT KF. Analyzed the data: WLR TT KF ADW. Contributed reagents/materials/analysis tools: WLR TT ADW. Wrote the paper: WLR ADW.","ADW has patents pending for the use of OX40 agonists in patients with cancer and has an ownership interest in Agonox, LLC. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","William L Redmond","WLR",4,TRUE,3,3,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
